NIFTY 50

Nothing to cheer about Sun Pharma's FY20 guidance, says Research Delta Advisor

Updated : May 29, 2019 01:00 PM IST

Mehta said Sudhir Valia stepping down from executive positions may not directly have any impact on the financial performance of the company
Sun Pharma's fourth-quarter earnings were largely in line with the market expectations and its earnings guidance for the fiscal year 2019-20 was neither great nor dismal
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV